Understanding how mRNA methylation affects heart development after birth
Mettl14 mediated mRNA methylation orchestrates postnatal cardiac development
This study is looking at how certain changes in genetic material affect heart development right after birth, with the hope of finding new ways to help heal heart injuries.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10950644 on NIH RePORTER |
What this research studies
This research investigates the role of mRNA methylation in the development of the heart during the early postnatal period. By studying how specific molecular mechanisms influence the heart's ability to regenerate, the research aims to uncover insights that could lead to improved therapies for heart injuries. The approach involves advanced sequencing techniques to analyze the regulation of gene expression during heart development, focusing on the methyltransferase complex that modifies mRNA. This could provide a better understanding of how to harness regenerative capabilities in cardiac therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are infants and young children with congenital heart defects or cardiac injuries, as well as adults with heart conditions seeking innovative therapies.
Not a fit: Patients with chronic heart disease unrelated to developmental issues or those who are not in the early stages of cardiac injury may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance heart regeneration after injury, significantly improving outcomes for patients with heart conditions.
How similar studies have performed: Other research has shown promising results in understanding cardiac regeneration through similar molecular approaches, indicating potential for success in this area.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Zhang, Manling — University of Pittsburgh at Pittsburgh
- Study coordinator: Zhang, Manling
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.